At a recent TIME100 Talks panel in New York, three leading health experts explored the concept of healthy aging and personalized prevention. The session, sponsored by Hims & Hers, focused on shifting from reactive treatment to a more proactive approach to men’s health. Dr. Dean Ornish, Dr. Anant Vinjamoori, and Alan Cohen joined moderator Alice Park to discuss how individuals can align medical care with their personal life goals, such as dancing at a child’s wedding or completing a long-pending project.
Dr. Vinjamoori, Chief Medical Officer of Hims & Hers, argued that standard medical terminology, such as ‘chief complaint’ or ‘problem list,’ often keeps conversations narrowly focused on current ailments. He suggested that physicians ask patients early in a visit about their long-term hopes, which can help guide preventive discussions and the interpretation of options like biological-age tests or new pharmaceuticals.
Alan Cohen, who chairs biological complexity and healthy longevity at Columbia University, addressed the complexity of defining aging. He noted that even scientific communities often disagree on what aging is and whether it can be accurately measured. Cohen contended that health is a more practical metric than chronological age. ‘Are you able to be and do the things that matter to you?’ he asked, suggesting that clinicians should assess functional abilities, such as whether a patient can walk to the store, rather than relying solely on biological age estimates.
The panel also addressed the rising trend of self-administered peptides. Dr. Vinjamoori cautioned that there is no single compound suitable for everyone and emphasized the need for clinical oversight, noting safety concerns raised by the U.S. Food and Drug Administration regarding compounded BPC-157. In contrast, Dr. Ornish, founder of the Preventive Medicine Research Institute, viewed GLP-1 drugs as a potential ‘jumpstart’ for lifestyle changes. He cited a large clinical trial involving adults with cardiovascular disease and overweight or obesity—excluding those with diabetes—which showed that semaglutide reduced the relative risk of heart attack, stroke, or cardiovascular death compared to a placebo.
When asked how individuals overwhelmed by health information should begin making changes, Dr. Ornish advocated for consistency over intensity. ‘If I don’t have time to meditate for an hour, do it for a minute,’ he advised. He suggested that even small actions, like walking around the room during phone calls, are valuable. ‘I think the consistency is more important than anything else,’ he concluded.
Sponsored by Hims? I would be skeptical, but the advice on small, consistent actions is actually quite sound.
As a nurse, I appreciate this shift. Reactive medicine is exhausting and often fails to address the root cause.
The warnings about self-administered peptides are crucial. People need to stop treating their bodies like chemistry experiments.
Is ‘walking to the store’ really a good health metric? That seems incredibly low for someone in their forties.
I love the idea of asking doctors about my long-term hopes. It makes appointments feel less like a factory line.
Finally, someone talking about consistency instead of just buying the latest miracle supplement. Small daily habits actually do matter.